Transcripts StemRIM

Stocks

Market Closed - Japan Exchange 12:00:00 21/08/2026 pm IST			5-day change	1st Jan Change
357.00 ^JPY	+0.56%		+2.59%	+35.74%

22/07	Stemrim Announces Patent Registration in Mexico for Redasemtide as Therapeutic Agent for Cartilage Disorders	CI
08/07	StemRIM Inc. Announces Patent Registration For Stem Cell Gene Therapy Technology SR-GT1 Aimed At Curative Treatment Of Dystrophic Epidermolysis Bullosa In South Korea	CI